Leoligin, the major lignan from Edelweiss, inhibits intimal hyperplasia of venous bypass grafts. (Q37193530)
Jump to navigation
Jump to search
scientific article published on 19 February 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Leoligin, the major lignan from Edelweiss, inhibits intimal hyperplasia of venous bypass grafts. |
scientific article published on 19 February 2009 |
Statements
Leoligin, the major lignan from Edelweiss, inhibits intimal hyperplasia of venous bypass grafts (English)
Ute Reisinger
Robert Stigler
Dominik Wiedemann
Tobias Mayr
Angelika M Vollmar
Johannes O Bonatti
Günther Laufer
David Bernhard
19 February 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference